Found: 34
Select item for more details and to access through your institution.
Prognostic and predictive markers of response to treatment in patients with locally advanced unresectable and metastatic pancreatic adenocarcinoma treated with gemcitabine/nab-paclitaxel: Results of a retrospective analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
What do patients and oncologists think about the evaluation and management of cancer-related anorexia-cachexia? The Quasar_SEOM study.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 12, p. 3479, doi. 10.1007/s12094-023-03212-7
- By:
- Publication type:
- Article
Recommendations and expert opinion on the treatment of locally advanced rectal cancer in Spain.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 12, p. 862, doi. 10.1007/s12094-011-0747-1
- By:
- Publication type:
- Article
Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapy.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 12, p. 843, doi. 10.1007/s12094-010-0607-4
- By:
- Publication type:
- Article
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 2041, doi. 10.3390/jcm11072041
- By:
- Publication type:
- Article
Do Clinical Trials Meet Current Care Needs? Views of Digestive Oncology Specialists in Galicia (Spain) Using the Delphi Method.
- Published in:
- Healthcare (2227-9032), 2021, v. 9, n. 6, p. 665, doi. 10.3390/healthcare9060665
- By:
- Publication type:
- Article
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2259, doi. 10.3390/cancers12082259
- By:
- Publication type:
- Article
Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?
- Published in:
- International Journal of Colorectal Disease, 2020, v. 35, n. 4, p. 739, doi. 10.1007/s00384-020-03509-x
- By:
- Publication type:
- Article
Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 3, p. 882, doi. 10.1002/cam4.1903
- By:
- Publication type:
- Article
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 11, p. 2877, doi. 10.1007/s12094-024-03605-2
- By:
- Publication type:
- Article
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 10, p. 2640, doi. 10.1007/s12094-024-03487-4
- By:
- Publication type:
- Article
Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies (PERSIST): a multicenter study protocol to evaluate efficacy of digital tools supporting cancer survivors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgery.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 567, doi. 10.1007/s00280-009-1197-0
- By:
- Publication type:
- Article
Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 403, doi. 10.1007/s00280-008-0749-z
- By:
- Publication type:
- Article
Combined effects of chemical fertilization and microbial inoculant on nutrient use efficiency and soil quality indicators.
- Published in:
- Scientia Agropecuaria, 2020, v. 11, n. 3, p. 375, doi. 10.17268/sci.agropecu.2020.03.09
- By:
- Publication type:
- Article
Indicadores de calidad de suelo en uva de mesa (Vitis vinifera cv. Thompson seedless) bajo manejo integrado de nutrición.
- Published in:
- Scientia Agropecuaria, 2018, v. 9, n. 1, p. 17, doi. 10.17268/sci.agropecu.2018.01.02
- By:
- Publication type:
- Article
Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 1, p. 69, doi. 10.1159/000505237
- By:
- Publication type:
- Article
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0269399
- By:
- Publication type:
- Article
Rechallenge with Anti-EGFR Treatment in RAS/BRAF wt Metastatic Colorectal Cancer (mCRC) in Real Clinical Practice: Experience of the GITuD Group.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 4, p. 565, doi. 10.1007/s11523-024-01062-z
- By:
- Publication type:
- Article
Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1271, doi. 10.1634/theoncologist.2018-0316
- By:
- Publication type:
- Article
Acondicionamiento de fuentes radiactivas en desuso de radio-226.
- Published in:
- Nucleus, 2023, n. 74, p. 32
- By:
- Publication type:
- Article
Diseño de cursos de protección radiológica para operadores de prácticas industriales.
- Published in:
- Nucleus, 2022, n. 70, p. 10
- By:
- Publication type:
- Article
CPHR: 35 años al Servicio de la Protección Radiológica, la Salud y el Medio Ambiente.
- Published in:
- Nucleus, 2020, n. 67, p. 6
- By:
- Publication type:
- Article
Desmantelamiento del irradiador autoblindado Gammacell 500.
- Published in:
- Nucleus, 2011, n. 50, p. 36
- By:
- Publication type:
- Article
Acondicionamiento de las fuentes de radio 226 en Cuba.
- Published in:
- Nucleus, 2011, n. 49, p. 40
- By:
- Publication type:
- Article
GESTIÓN DE LOS DESECHOS RADIACTIVOS EN CUBA.
- Published in:
- Nucleus, 2005, n. 37, p. 54
- By:
- Publication type:
- Article
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study).
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-865
- By:
- Publication type:
- Article
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study).
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-865
- By:
- Publication type:
- Article
Venous Thromboembolism In Cancer Patients: "From Evidence to Care".
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296221098717
- By:
- Publication type:
- Article
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article